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Background: Improvements in the iron status of a population as result of food fortification are expected at the
long term. In Brazil, the effectiveness of mandatory flour fortification with iron has been evidenced mostly from
surveys on gestational anemia after 1 or 2 years from its implementation, in 2004. Our aim was to assess
hemoglobin (Hb) concentrations and the prevalences of anemia and linked erythrocyte morphology patterns
among pregnant women in 2006 and 2008.
Methods: The study design was retrospective and cross-sectional. The analysis was based on secondary data in 546
medical records from women at the times of their first prenatal attendance in 13 public primary healthcare units
of the Butantan Administrative Region from São Paulo (SP), Brazil. Anemia was evaluated from Hb concentration
(cut-off <11.0 g/dL) and erythrocyte morphology patterns from mean corpuscular volume (MCV), mean corpuscular
Hb concentration (MHC), and red cell distribution widths (RDW). Recorded sociodemographic and obstetric data
included maternal age, gestational age, ethnoracial self-classification, and residence type. Student’s t tests, analysis
of variance, Chi-squared tests, and multiple linear and logistic regressions were employed in the statistical analysis
using a significance level of 5 %.
Results: The prevalence of anemia was 9.7 % in 2006 and 9.4 % in 2008 (P = 0.922), with no significant difference in
mean Hb concentrations (P = 0.159). Normocytosis (normal MVC), normochromia (normal MHC), and anisocytosis
(high RDW) were found in most anemia cases, suggesting that the low Hb concentrations resulted from mixed
causes. In multiple regression analysis, gestational age at the first prenatal attendance was an independent predictor of
low Hb and of having anemia. Moreover, black ethnoracial self-classification was associated with lower Hb.
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Conclusions: The prevalence of gestational anemia was low among women in both of the studied periods,
representing a mild public health problem. Our results highlight the importance of early prenatal care as a means of
reducing gestation-associated risks. The erythrocyte morphology pattern found in most cases of low Hb levels suggests
that, besides iron deficiency, hemoglobinopathies and nutritional deficiencies of folate and vitamin B12 are common
complicating factors of gestational anemia in our setting.
Keywords: Hemoglobin, Erythrocyte morphology parameters, Iron deficiency anemia, Pregnancy, Prenatal careBackground
Women with low body iron stores at the beginning of
pregnancy are at a considerable risk of developing iron
deficiency anemia because the body’s requirement for
this mineral substantially increases with gestation [1]. Of
the total amount of iron that is needed by an adult
mother and her fetus during normal pregnancy, more
than 90 % must be available during the second and third
trimesters, which corresponds to about 5.5 mg of iron
daily [2]. Because the bioavailable iron from women’s
diets and their pre-gestational body iron stores are typi-
cally insufficient to meet this high requirement, it is of
paramount importance to ensure adequate iron supple-
mentation for pregnant women [3].
Based on these facts, the Brazilian Ministry of Health
has been encouraging iron supplementation during preg-
nancy for at least the last three decades [4]. In 2005, this
initiative was reinforced by the National Iron Supple-
mentation Program (Programa Nacional de Suplementa-
ção de Ferro), which aimed to ensure prophylactic iron
supplementation for all pregnant women after 20 weeks
of gestation [5]. The diagnosis of anemia in this group
has also been a top priority for public health programs,
as evidenced by its inclusion as a preliminary obligation
for healthcare units in the context of the Humanization
of Prenatal and Childbirth Care Program (Programa de
Humanização do Pré-Natal e Nascimento) [6].
As a complementary action in the Brazilian govern-
ment’s efforts to fight iron deficiency, iron fortification
of wheat and maize flours has been mandated in all na-
tional territories since July 2004 [7]. According to this
program, a daily intake of 100 g of flour should provide
at least 30 % of the recommended dietary allowance
(RDA) of iron for a healthy adult [8], which is expected
to reduce the prevalence of nutritional iron inadequacy
in the population. However, following the program’s
implementation, there has been no internal evaluation of
body iron status in the target population groups. Further-
more, there have been contradictory findings regarding
the changes in anemia prevalence during the post-
fortification period, which have prevented definitive con-
clusions from being reached on this issue [9–14].
In a nationwide evaluation of women at their first
prenatal attendance in public healthcare facilities,Fujimori et al. reported a fall in the prevalence of
anemia after flour fortification, especially in the
northeast and north regions of Brazil. During the
pre-fortification period, the frequency of anemia
cases varied from 32.2 to 37.4 % in these areas [11].
Similar findings were reported for pregnant women
from Rio de Janeiro (RJ) in the southeast region [12].
On the other hand, the anemia prevalence rates in
the same groups of women from the cities of São
Paulo (SP) and Maringa (PR) did not seem to differ
between the post-fortification period (8.6 and 9.4 %)
and the pre-fortification period (before 2004, 9.2 and
12.3 %) [10, 13].
Although iron deficiency is considered to be the cause
of 50 % of anemia cases in the world, this proportion
varies markedly across different populations [15, 16].
Furthermore, it is described that for a given prevalence
of iron deficiency anemia, about two to five times more
individuals are at risk for iron deficiency without anemia
[17]. Hence, a reliable assessment of body iron status de-
pends not only on Hb but also on other more expensive
laboratory assays such as serum ferritin, serum transfer-
rin receptor, and transferrin saturation index [18]. The
parameters of erythrocyte morphology, such as mean
cell volume (MCV), mean cell Hb (MCH), and red cell
distribution width (RDW), provide cheaper markers of
late changes in iron status. Usually, severe cases of iron
deficiency present microcytosis (low MCV), hypochro-
mia (low HCM), and anisocytosis (high RDW) [19].
Monitoring the hemoglobin (Hb) response to an in-
crease in the iron intake from dietary sources or supple-
mentation can further proof the diagnosis of iron
deficiency anemia [17].
The aim of the present study was to assess Hb concen-
trations and the prevalence of anemia as well as their as-
sociated factors among pregnant women evaluated at
the times of their first prenatal attendance in primary
healthcare units from the Butantan Administrative
Region (São Paulo municipality, Brazil) during the years
2006 and 2008. We have also described the erythrocyte
morphology patterns that were associated with anemia
during these two periods, which corresponded to the
second and fourth years after the effective implementa-
tion of mandatory iron fortification of flours in Brazil.
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Study population
The study design was retrospective and cross-sectional.
The analysis relied on secondary data that had been ob-
tained from the medical records of pregnant women
who were attending first prenatal care appointments at
13 primary healthcare units in the Butantan Administra-
tive Region (São Paulo) during 2006 and 2008. This
Region, which covers an area of 56.1 km2, belongs to
one of five districts that are controlled by the municipal-
ity’s Centre-West Regional Health Care Coordination
center. Each primary healthcare unit attends to the
needs of the population according to guidelines from the
Brazilian Ministry of Health concerning public health
and safety, disease prevention, diagnosis, treatment, and
rehabilitation. In 2008, the primary healthcare units
from the Butantan Administrative Region provided pre-
natal care services for around 3700 pregnant women.
To calculate the study sample size, we used the for-
mula n = [z2 × p × (1 − p)] × d−2 [20], where p is the ex-
pected estimate (0.086), z is the percentile of the normal
distribution (1.96), and d is the maximum absolute error
(0.035). Based on this formula, a minimum sample of
247 individuals was established for each year of the
study. The expected prevalence was obtained in a previ-
ous study that had been conducted with part of the
target population between 2005 and 2006 [10].
Because improvements in iron status were expected to
result from long-term increases in iron intake from
fortified foods [21], a 2-year interval was chosen for the
assessment. Therefore, pregnant women who were
attended by the primary healthcare units in 2007 were
not included in the study.
Data collection
In order to avoid sample losses, 500 medical records of
pregnant women from each year of the study were
initially sorted by random draw from the Butantan
Administrative Region’s central databank. In a first selec-
tion step, medical records concerning first prenatal care
assistance entered in the study’s databank only if they
described the following: (1) maternal age; (2) date of last
menstruation; (3) complete laboratorial results for Hb,
MVC, MCH, and RDW; (4) absence of diabetes, hyper-
tension, or liver or kidney pathology diagnosis; and (5)
no history of use of iron-containing supplements. Then,
of the resulting medical records (n = 772), just those that
also showed complete information about the woman’s
ethnoracial self-classification and residential building
type were selected for the final sample. With the data
that were retained in the first selection step, compari-
sons of obstetric and hematologic variables between
women included or not the final sample were carried
out in order to check any sampling bias possibly drivenby exclusion of records with inconsistent sociodemo-
graphic information.
The number of days between the last menstruation
and the blood collection was used to estimate the gesta-
tional age at the time of the first prenatal care attend-
ance and to assign the corresponding trimester of
pregnancy as first (<13 weeks), second (13–27 weeks), or
third (>27 weeks) [22]. Women younger than 20 years
old were considered adolescent mothers. Ethnoracial
self-classifications were based on the categories adopted
by the Brazilian Institute of Geography and Statistics (IBGE)
in census surveys: white, mixed (“pardo” in Portuguese),
black, yellow (Asian Brazilian), or indigenous (Native
American) [23]. The type of current residence was catego-
rized as a brick house/apartment or as other type of hous-
ing, according to reported characteristics from the domicile
(house or apartment, slum or tenements) and the building
materials that had been used to build the walls (brick or
wood). When available in the medical records, data
regarding maternal schooling (<8 or ≥ 8 years of study),
occupation (remunerated or non-remunerated job), and
marital status (with or without a partner) were also
obtained.
Hematological determinations were made by the
Butantan Administrative Region’s central laboratory with
the aid of an automatized and daily-calibrated Sysmex
XE-2100D system (Roche Diagnostics, Meylan, France),
based on blood samples from individuals who had fasted
for at least 8 h. The occurrence of anemia was evaluated
from Hb concentration using the pregnant specific cut-
off (<11.0 g/dL) recommended by the World Health
Organization (WHO) and the Brazilian Ministry of Health
[24, 25]. Age-specific WHO reference values were also
used to define normality for MCV (78–98 and 81–99 fL
for 15- to 17.9- and ≥18-year-old women, respectively)
and MCH (26–34 pg, irrespectively of age) [24]. Anisocy-
tosis was considered present for RDW >14 % [25].
Statistical analysis
Data analysis was performed with the Statistical Package
for Social Sciences (SPSS), version 20.0 (IBM Corp.,
Armonk, USA). The normality and homoscedasticity of
the distributions of continuous variables were assessed
using Kolmogorov-Smirnov and Levene tests, respect-
ively. Descriptive data were summarized as means and
standard deviations (SDs) or as absolute and relative fre-
quencies. Student’s t tests, analysis of variance (ANOVA)
followed by Tukey’s post hoc tests, and Chi-squared
tests were used to detect bivariate associations (P < 0.05,
two-sided).
To assess possible predictors of Hb concentration and
anemia prevalence, multiple linear and logistic regression
analysis were employed using the stepwise method. Ini-
tially, the following variables were used in the regression
Table 1 Descriptive characteristics of pregnant women at first
prenatal attendance in 2006 and 2008
Demographic characteristics1 2006 2008 P value2
% N % n
Maternal age
< 20 years 16.6 43 17.8 51 0.718
≥ 20 years 83.4 216 82.2 236
Total n 259 287
Gestational period
First trimester 47.1 122 40.4 116 0.140
Second trimester 45.2 117 47.7 137
Third trimester 7.7 20 11.8 34
Total n 259 287
Ethnoracial self-classification
White 54.4 141 52.3 150 0.549
Mixed (“Pardo”) 39.0 101 38.7 111
Black 6.6 17 9.1 26
Total n 259 287
Residence type
Brick house/apartment 74.9 194 68.6 197 0.105
Another type of housing 25.1 65 31.4 90
Total n 259 287
Schooling
< 8 years of study 59.0 131 37.6 99 <0.001
≥ 8 years of study 41.0 91 62.4 164
Total n 222 263
Occupation
Remunerated job 84.1 175 57.1 117 <0.001
Non-remunerated job 15.9 33 42.9 88
Total n 208 205
Marital status
With a partner 55.5 116 48.6 101 0.156
Without a partner 44.5 93 51.4 107
Total n 209 208
1Information on schooling, occupation, and marital status were not available in
all of the studied medical records
2P values refer to comparisons of category frequencies between the groups,
using Chi-squared tests. P-value in italics indicates statistical significances
Machado et al. Nutrire  (2016) 41:19 Page 4 of 10model: year group (2008 vs. 2006), maternal age (years),
gestational age (weeks), ethnoracial self-classification
(black vs. white and mixed), and residence type (brick
house/apartment vs. other types of housing). Subsequently,
variables with non-significant associations (P > 0.05) were
sequentially removed. There was no substantial change
in model parameters after the removal or inclusion of
non-significant variables, and we decided to present β
values, odds ratios (OR), and corresponding 95 % confi-
dence intervals for the original models (those with all
variables included).
Goodness-of-fit was checked for the multiple logistic
and linear regression models by using Hosmer and
Lemeshow’s test and by analyzing the residuals (asses-
sing normality and checking for visual patterns in the
distribution of plotted values), respectively.
Results
Of 1000 medical records initially sorted, 772 were
retained in the first sampling step, and 546 in the second
one. These were included in the final sample, which
comprised 259 records from 2006 and 287 records from
2008. No significant difference of maternal ages, gesta-
tional ages, and hematological parameters were observed
between women included in the final sample and those
excluded due to incomplete sociodemographic data
(P > 0.05, data not shown). Homogenous distributions
of the gestational period, maternal age, ethnoracial
self-classification, and residence type categories were
also observed in the two studied year groups (Table 1).
The mean maternal and gestational ages at first pre-
natal attendance in 2006 and 2008 were 25.3 ± 6.0
and 26.1 ± 6.5 years (P = 0.123) and 15.5 ± 7.3 and
16.2 ± 7.6 weeks (P = 0.260), respectively.
More than half of the women self-reported their
ethnoracial group as white, and more than two thirds
resided in a brick house or apartment. No woman self-
reported her ethnoracial group as yellow or indigenous.
Although some of the medical records were incomplete
regarding maternal schooling, occupation, and marital
status, the available data indicated that the proportion of
women who had completed elementary schooling
(≥8 years of study) was lower in the 2006 group than in
the 2008 group. Nonetheless, in the latter group, a signifi-
cantly higher proportion of women had a non-remunerated
job. Approximately half of the women reported that
they did not have a current partner (Table 1).
In both the 2006 and 2008 groups, average Hb
concentrations varied across the gestational period cat-
egories; however, no difference was found when the
values from the 2 years were compared. Accordingly, the
overall prevalences of anemia did not differ between
2006 and 2008 groups (9.7 vs. 9.4 %, P = 0.922). Women
whose first prenatal attendance occurred during thethird trimester of pregnancy had the highest anemia
prevalences (40.0 % in 2006 and 23.5 % in 2008)
(Table 2).
In all gestational periods, about one third of the anemic
women showed a microcytic-hypochromic erythrocyte
morphology pattern. No macrocytic (high MCV) case of
anemia was found. Anemia and anisocytosis accounted for
46 and 63 % of all normocytic-normochromic and
microcytic-hypochromic cases and had a prevalence of
3.8 % in the 2006 group and 5.2 % in the 2008 group
Table 2 Hemoglobin (g/dL) and prevalence of anemia among
women at first prenatal attendance by gestational trimester in
2006 and 2008
Variable 2006 2008 P value1
Mean SD Mean SD
Hemoglobin
First trimester 12.65a 1.00 12.58a 1.03 0.597
Second trimester 12.16b 1.08 12.04b 0.91 0.252
Third trimester 11.40c 1.26 11.58c 1.04 0.572
Total 12.33 1.11 12.20 1.03 0.159
2006 2008 P value2
% n % n
Anemia
First trimester 4.9a 6 5.2a 6 0.929
Second trimester 9.4a 11 9.5a 13 0.981
Third trimester 40.0b 8 23.5b 8 0.201
Total 9.7 25 9.4 27 0.922
1P values refer to comparisons of means between groups, using ANOVA tests
2P values refer to comparisons of category frequencies between groups, using
Chi-squared tests
a,b,cMeans or category frequencies with different superscripts within the same
column are significantly different according to Tukey’s post hoc or Chi-squared tests
SD standard deviation
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anemia did not differ significantly between the 2-year
groups (3.9 % in 2006 vs. 2.1 % in 2008, P = 0.221).
On the other hand, in the descriptive analysis, the fre-
quency of microcytic-hypochromic anemia was found to
be about three times higher among women who self-Table 3 Hemoglobin (g/dL) and prevalence of anemia among wom
Demographic characteristics n Hemoglobin
Mean SD P value1
Maternal age
Adolescents 94 12.21 1.04 0.578
Adults 452 12.27 1.08
Gestational period
First trimester 238 12.61a 1.02 <0.001
Second trimester 254 12.10b 0.99
Third trimester 54 11.52c 1.12
Ethnoracial self-classification
White 291 12.29 1.03 0.150
Mixed (“Pardo”) 212 12.30 1.14
Black 43 11.96 1.02
Residence type
Brick house/apartment 391 12.23 1.03 0.262
Another type of housing 155 12.35 1.17
1P values refer to comparisons of means between groups, using Student’s t or ANO
2P values refer to comparisons of frequencies between groups, using Chi-squared te
a,b,cMeans or category frequencies with different superscripts within the same colum
SD standard deviationreported as black, when compared those who self-reported
as white or mixed (Table 3).
Multiple regression analysis corroborated the influence
of gestational age on Hb concentrations and presence of
anemia. A fall of 0.04 g/dL in Hb concentration and an
increase of 8.9 % in the probability of having anemia
were observed for each additional week of gestational
age that had elapsed before the beginning of prenatal
care. Moreover, independently of other tested variables,
women who self-reported as black showed Hb concen-
tration 0.34 g/dL lower than that estimated for women
who self-reported other ethnoracial categories (white
and mixed) (Table 4).Discussion
By surveilling trends in the diet and health status of tar-
get population groups, valuable information can be ob-
tained on the expected impact of large-scale nutrition
interventions [26]. Here, we assessed anemia prevalence
among pregnant women who attended primary health-
care units in the region of Butantan (São Paulo-SP,
Brazil) after 2 and 4 years after the implementation of
the national flour iron fortification program. We ob-
served that anemia prevalence did not differ among
women from 2006 and from 2008 and that it was a mild
public health problem in both periods (overall preva-
lences <10 %) according to the WHO criteria for the
classification of epidemiological severity [17].
Our results are similar to those by Sato et al. in a com-
parison of pre- and post-fortification prevalence rates ofen at first prenatal attendance by descriptive characteristics
Anemia Microcytic-hypochromic anemia
% n P value2 % n P value2
8.5 8 0.713 3.2 3 0.870
9.7 44 2.9 13
5.0a 12 <0.001 1.7a 4 0.011
9.4a 24 2.8a 7
29.6b 16 9.3b 5
8.2 24 0.426 2.1a 6 0.031
10.4 22 2.8a 6
14.0 6 9.3b 4
9.0 35 0.469 3.1 12 0.757
11.0 17 2.6 4
VA tests. P-values in italics indicate statistical significance
sts. P-values in italics indicate statistical significance
n are significantly different according to Tukey’s post hoc or Chi-squared tests
Table 4 Multiple linear and logistic regression models of predictors of Hb concentrations and anemia prevalence
Variable Hemoglobin model1 Anemia model2
β 95 % CI P value OR 95 % CI P value
Year group (2008 vs. 2006) -0.102 -0.275; 0,070 0.244 0.870 0.481; 1.564 0.646
Maternal age (years) 0.006 -0.008; 0.019 0.429 1.015 0.970; 1.062 0.510
Gestational age (weeks) -0.044 -0.055; -0.032 <0.001 1.089 1.053; 1.127 <0.001
Ethnoracial self-classification (black vs. white and mixed) -0.337 -0.656; -0.018 0.039 1.858 0.722; 4.785 0.199
Residence type (another type of housing v. brick house/apartment) 0.133 -0.058; 0.323 0.171 1.282 0.681; 2.4115 0.441
1Multiple linear regression with Hb concentration (g/dL) as the dependent variable (n = 546).P- value in italics indicates statistical significance
2Multiple logistic regression with anemia (Hb < 11 g/dL) as the dependent variable (n = 546). Hosmer & Lemeshow: P = 0.176
OR odds ratio, CI confidence interval
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healthcare unit from the same region [10]; and also to
those by Guerra et al. (prevalence of 12.4 %, n = 346),
16 years before the implementation of the national flour
iron fortification program [27]. Nevertheless, these rates
differ substantially from that estimated by the WHO in
2006 (29.1 %) [15]. Further, these anemia prevalence
rates were also lower than those reported by studies in
poorer municipalities from north, northeast, or mid-
west regions of the country (22–50 %) [11, 14, 28, 29].
These contrasting findings agree with the evidence that
social and economic inequalities are major determi-
nants of regional differences in the occurrence of
anemia [11, 30, 31].
We found no evidence of a significant fall in anemia
prevalence between 2006 and 2008 nor when we com-
pared it to those rates reported in pre-fortification pe-
riods [10, 27]. Therefore, despite an apparent trend of
improvement in women’s educational level, it is possible
that causes other than iron deficiency may account for
most cases of anemia in the studied setting. After asses-
sing erythrocyte morphology patterns, we found that
microcytic-hypochromic anemia, the most current blood
picture of severe iron deficiency, accounted for a minor-
ity of cases in both studied years. However, we were not
able to estimate the actual frequency of iron deficiency
anemia among those women because of the lack of spe-
cific laboratory indicators of body iron status.
In fact, it is estimated that up to 40 % of patients with
a normocytic-normochromic erythrocyte morphology
pattern present actual iron deficiency [19]. Moreover,
the coexistence of folate and/or vitamin B12 and iron
deficiencies, which lead to the release of both microcytic
and macrocytic erythrocytes in the peripheral blood, is
associated with the normalization of estimated values of
MCV [19]. Therefore, in this anemia of mixed causes,
there is a marked anisocytosis and RDW determination
may help the diagnosis [25, 32]. In our study, of all of
the normocytic-normochromic anemia cases, almost half
were associated with anisocytosis, hence suggesting thatthe women could indeed have been iron deficient. How-
ever, it is worth noting that if other nutritional deficien-
cies were also present in these cases, then dietary or
pharmacologic interventions that use iron as the only
measure could have a limited effect on anemia preven-
tion and control [17, 33].
In addition, iron interventions could not have a
strong positive impact on Hb concentrations in car-
riers of hereditary hemoglobinopathies. Nonetheless,
from a worldwide perspective (and besides iron defi-
ciency), the alpha- or beta-thalassemia traits should
be considered as a common cause of low Hb, MCV, and
HCM values among apparently healthy people [24].
Among Brazilians, thalassemia trait is a possible cause of a
considerable proportion of mild microcytic-hypochromic
anemia cases, most of which may be mistreated with
iron supplementation in the clinical setting (if the
nutritional iron deficiency is not a coincident compli-
cating factor) [34–36].
It is difficult to differentially diagnose thalassemia
traits from iron deficiency anemia without molecular or
chromatographic tests, particularly when multiple condi-
tions are present. However, the identification of anisocy-
tosis may be useful because “pure” thalassemia traits
usually lead to a production of erythrocytes with lower
size variation than does the iron deficiency [25, 37–39].
In this sense, if we considered all of the diagnosed
microcytic-hypochromic cases that were accompanied
by normal values of RDW in our study, we could infer
that one third of the women with this erythrocyte
morphology pattern could not have severe iron defi-
ciency at the time of the evaluation.
In Brazil, there are no data on the actual prevalence of
hemoglobinopathies. However, many regional studies
have shown that the alpha-thalassemia trait is not un-
common, especially among Afro-descendants or individ-
uals who self-classify as black [40, 41]. Viana-Baracioli
studied 696 pregnant women from 12 municipalities in
the São Paulo State and found a prevalence of 10.7 % for
hemoglobinopathies, with alpha and beta-thalassemia
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respectively [42]. Interestingly, alpha-thalassemia was
apparently associated with ethnoracial classification,
since it was found in 11.1 % of black women and 5.9 %
of white women in Viana-Baracioli’s study [42].
In our study, comparing women who self-reported as
black with those who self-reported as white or mixed, we
observed a higher frequency of microcytic-hypochromic
anemia (univariate analysis) and lower mean values of Hb
concentrations (multiple regression model). These trends
have no great clinical significance because ethnoracial
self-classification was not an independent predictor for
the occurrence of anemia. However, data from the
National Demographic and Health Survey (Pesquisa
Nacional de Demografia e Saúde (PNDS)) show that non-
pregnant women who self-reported as black have a higher
prevalence of anemia on the national level [31]. Inter-
national guidelines note that individuals with African
ancestry indeed show lower Hb concentrations, irrespect-
ive of iron status, and should be evaluated with an
ethnoracial-specific Hb cut-off to define anemia (1.0 g/dL
lower) [17, 18]. However, whether this assumption is valid
for individuals who self-report as black in our genetically
admixed population is an issue that requires further
confirmation.
Although the race, ethnicity, and skin color classifica-
tions that are frequently employed in epidemiological
studies may correlate with ancestry, they are usually
nonspecific and inaccurate measures of underlying gen-
etic factors in highly admixed populations [43–45].
Moreover, because ethnoracial self-classification is a so-
cial construct, it may be a proxy for diverse environmen-
tal exposures [46]. Some studies have reported that
Brazilians who self-report as black (followed by those
who self-report as mixed) are more prone to have un-
favorable socioeconomic conditions and to suffer discrim-
ination [43], including in the care delivered by public
health facilities [47]. Importantly, in our multiple regres-
sion model, black ethnoracial self-classification remained
a significant predictor of lower Hb concentrations, even
with the adjustment for current residence type, a potential
indicator of socioeconomic conditions [48].
We also found that Hb was inversely correlated with
gestational age at first prenatal attendance. Some re-
searchers have emphasized the importance of commen-
cing prenatal care at the very beginning of pregnancy
(first trimester) in order to avoid pregnancy-associated
risks [49, 50]. The women included in this study were
presumably not taking iron supplementation. It is note-
worthy that gestation progressively depletes body iron
stores [1–3]; therefore, it is not surprising that the gesta-
tional age at the first prenatal attendance was an inde-
pendent predictor of both Hb concentrations and
prevalence of anemia. The fact that more than half ofthe studied women began prenatal care during the sec-
ond or third trimester of pregnancy may have contrib-
uted to these findings.
A recent systematic review has examined the effective-
ness of flour fortification programs in various countries
[51]. According to this review, most of the published
studies have been importantly limited by the decision to
use anemia as the primary outcome, instead of evalua-
tions of specific biomarkers of the nutrients (iron and
folic acid) that were added to flours [51]. A positive
aspect of our study is that, in addition to investigating
Hb concentrations, we have used the parameter of
erythrocyte morphology to characterize cases of anemia.
Notably, these indices form part of the complete blood
count (CBC) test, which is freely available at the Brazilian
primary healthcare units [24]. On the other hand, the un-
availability of serum ferritin measurements, which is the
most specific biomarker of iron stores (in the absence of
inflammation) [17–19, 25], precluded the assessment of
iron deficiency prevalence, as previously mentioned.
Other limitation is the fact that we used MCV, HCM,
and RDW cut-off values that were not specific for preg-
nant women. Indeed, studies that apply erythrocyte
morphology parameters to diagnose anemia in pregnant
women are scarce [52–56].
The use of secondary data represents another limita-
tion to our study because we were not able to confirm
the quality of the information that was obtained from
medical records. Moreover, data completeness could
have influenced the representativeness of the selected
samples since we excluded women with missing infor-
mation regarding the inclusion criteria. Nonetheless, be-
cause women in the initial study sample and the final
study sample did not differ in maternal age, gestational
age, and hematological parameters, we believe that there
were no large selection biases. The sample, however, was
limited to apparently healthy women who attended the
public health facilities in the region, and did not neces-
sarily reflect the entire population.
Considering our data, we realized that we could not
expect iron fortification to have a strong impact on ges-
tational anemia in the studied population, since only a
small proportion of women had severe iron deficiency
as the sole cause of anemia (prevalence of microcytic-
hypochromic anemia accompanied by anisocytosis).
Nonetheless, in the logistic regression analysis, a non-
significant 13 % lower odds ratio for anemia was esti-
mated for women from the 2008 group, which could
signalize a trend for a delayed effective impact of this
program after 4 years from its implementation. How-
ever, our small sample size implied in a low statistical
power to test difference in prevalences between the
studied periods, arguing for larger studies and longer-
term assessments.
Machado et al. Nutrire  (2016) 41:19 Page 8 of 10In respect of the above-cited limitation, we were not
also able to assess the effects of the year variable on the
probability of having microcytic-hypochromic anemia
or on Hb concentrations and the prevalence of anemia
by gestational period. Nevertheless, it is worth noting
that the frequency of anemia during the third trimester
of pregnancy was almost two times lower in 2008 than
in 2006, although the difference was not statistically
significant (P = 0.201). Additionally, the proportion of
all anemia cases that were microcytic-hypochromic was
numerically smaller in 2008 (22.3 %) than in 2006
(40.2 %), although again the difference was not statisti-
cally significant.
Our results highlight the importance of performing
detailed blood analysis in pregnant women attending
prenatal care, especially among those with low Hb con-
centrations. Although the costs from these assays for
iron deficiency diagnosis (e.g., serum iron, ferritin, and
total iron binding capacity) may be prohibitive for large
epidemiological studies, such tests could be prescribed
during prenatal care by Sistema Único de Saúde (the
healthcare system of the Brazilian government) [23]. The
collection of this type of data would assist in the diagno-
sis of iron deficiency with and without anemia as well as
cases of anemia caused by factors others than iron
deficiency, in particular by nutritional deficiencies of fol-
ate, vitamin B12, or other micronutrients, and also by
hemoglobinopathies.
Conclusions
This study has demonstrated a low prevalence of anemia
among women enrolled in prenatal care provided by
primary healthcare units of the Butantan Administrative
Region (São Paulo municipality, Brazil) after 2 and 4 years
that iron fortification program became mandatory.
Among the diagnosed cases, the blood picture of severe
iron deficiency (microcytosis, hypochromia, and anisocy-
tosis) was not common. Therefore, it is possible that other
nutritional deficiencies and hemoglobinopathies were
frequent causes and/or complicating factors of anemia in
this setting.
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